26L-29169-37602
2 vaccinations
3 coded responses
13 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2021-04-28
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Registered in v-safe
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Joint pains · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-03
- 2021-05-04
-
2021-05-11
Survey response — day 14, dose 2MedDRA: Arthralgia, Mobility decreased — Feeling: FairFree text: My shoulder joint pain and range of motion (swelling +pain) has returned and worsened again (similar to 4 days post-shot). I believe this is due to the incorrect placement of the shot (at the acromion process, not 3 fingers below into the deltoid).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-18
-
2021-05-25
Survey response — day 28, dose 2MedDRA: Arthralgia, Joint injection, Joint range of motion decreased, Muscular weakness, Product administered at inappropriate site — Feeling: Good · Be unable to do your normal daily activitiesFree text: My shoulder is still only at 40% of normal strength and range of motion. Vaccine was injected into my shoulder joint, not my deltoid.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-01
Survey response — day 35, dose 2MedDRA: Arthralgia, Grip strength decreased, Hypoaesthesia, Joint range of motion decreased, Paraesthesia, Product administered at inappropriate site — Feeling: GoodFree text: Still have issues with range of motion of my shoulder, pain, decreased grip strength, and numbness/tingling. Shot was into my shoulder, not the deltoid.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
- 2021-07-29
- 2021-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech |
Free text
Release 8 — day 14, dose 2
Symptoms: My shoulder joint pain and range of motion (swelling +pain) has returned and worsened again (similar to 4 days post-shot). I believe this is due to the incorrect placement of the shot (at the acromion process, not 3 fingers below into the deltoid). cut off by CDC
Release 8 — day 28, dose 2
Symptoms: My shoulder is still only at 40% of normal strength and range of motion. Vaccine was injected into my shoulder joint, not my deltoid.
Release 8 — day 35, dose 2
Symptoms: Still have issues with range of motion of my shoulder, pain, decreased grip strength, and numbness/tingling. Shot was into my shoulder, not the deltoid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Grip strength decreased | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Joint injection | ○ | ✓ | ○ |
| SD | Joint range of motion decreased | ✓ | ✓ | ✓ |
| SD | Mobility decreased | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Product administered at inappropriate site | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release